Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Fish and Richardson
Queensland Health
US Army

Generated: July 20, 2017

DrugPatentWatch Database Preview

ANTIVERT Drug Profile

« Back to Dashboard

What is the patent landscape for Antivert, and when can generic versions of Antivert launch?

Antivert is a drug marketed by Casper Pharma Llc and is included in one NDA.

The generic ingredient in ANTIVERT is meclizine hydrochloride. There are seventeen drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the meclizine hydrochloride profile page.

Summary for Tradename: ANTIVERT

Suppliers / Packagers: see list1
Bulk Api Vendors: see list26
Clinical Trials: see list2
Patent Applications: see list4,114
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ANTIVERT at DailyMed

Pharmacology for Tradename: ANTIVERT

Drug ClassAntiemetic
Physiological EffectEmesis Suppression
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Casper Pharma Llc
meclizine hydrochloride
TABLET, CHEWABLE;ORAL010721-005Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Casper Pharma Llc
meclizine hydrochloride
TABLET;ORAL010721-001Jan 20, 1982DISCNNoNo► Subscribe► Subscribe
Casper Pharma Llc
meclizine hydrochloride
TABLET;ORAL010721-006Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Casper Pharma Llc
meclizine hydrochloride
TABLET;ORAL010721-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Chinese Patent Office
Daiichi Sankyo
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:

Google Plus